Search

Your search keyword '"Ipilimumab -- Forecasts and trends"' showing total 61 results

Search Constraints

Start Over You searched for: Descriptor "Ipilimumab -- Forecasts and trends" Remove constraint Descriptor: "Ipilimumab -- Forecasts and trends"
61 results on '"Ipilimumab -- Forecasts and trends"'

Search Results

1. LATEST COMPANY NEWS

2. BioAtla Highlighted Clinical Program and Pipeline Updates at Virtual R&D Day

3. Horseradish Peroxidase Market Set to Reach USD 100 million by 2031, Surging at a 7.3% CAGR - Transparency Market Research, Inc

4. FORM 8-K: BioAtla, Inc. Files Current Report (Dec 13, 2023)

5. BioAtla Hosting Virtual R&D Day to Highlight BA3071 CAB-CTLA-4 Phase 1 Data in Multiple Solid Tumor Types

6. BioAtla to Host Virtual R&D Day to Review BA3071 CAB-CTLA-4 Phase 1 Data in Multiple Solid Tumor Types on Wednesday, December 13, 2023

7. Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Metastatic Uveal Melanoma

8. Immunotherapy Drugs Market To Reach USD 235.4 Billion By 2032, Says DataHorizzon Research

9. Cutaneous Melanoma Market Set to Experience Unprecedented Growth During the Forecast Period (2023-32) - Estimates DelveInsight | BMS, Merck, Eisai, Regeneron, IO Biotech, Linnaeus, Iovance

10. Lung Cancer Treatment Market Revenue to Cross USD 102 billion by 2031, Expanding at a CAGR of 9.8% Says, Transparency Market Research Inc

11. Toll-like Receptor Agonists Pipeline Insight | Companies - InDex Pharmaceuticals, Mologen, Idera Pharmaceuticals, Exicure, Birdie Biopharmaceuticals/ Seven and Eight Biopharmaceuticals, and Others

12. CD276 Antibody Clinical Trials & Market Sales Forecasts, 2028

13. Adagene Reports Full Year 2022 Financial Results and Provides Corporate Update

14. Kaposi's Sarcoma Market to Observe Stunning Growth During the Forecast Period (2022-2032), Evaluates DelveInsight | Key Companies - SkinDermic, Aphios, TTY Biopharm, NeoImmuneTech, Vasgene, BMS

15. Metastatic Merkel Cell Carcinoma Pipeline Analysis Demonstrates Novel 13+ Therapies at the Horizon Expected to Transform the Treatment Paradigm

16. Toll- Like Receptor Agonist Pipeline Analysis Demonstrates Novel 60+ Therapies at the Horizon Expected to Transform the Treatment Paradigm | DelveInsight

17. Drugs for Immunotherapy Global Market Report 2023

18. Immune Checkpoint Inhibitors Global Market Report 2022: Featuring Bristol-Myers Squibb, Merck, Novartis, Pfizer & More

19. Immune Checkpoint Inhibitors Global Market Report 2022: Featuring Bristol-Myers Squibb, Merck, Novartis, Pfizer & More

20. Head And Neck Cancer Therapeutics Market Is Estimated To Grow At CAGR Of 8.5 %, 2022-2028 | Latest Industry Coverage By Douglas Insights

21. Cardiotoxicity Market is Predicted to Exhibit Remarkable Growth by 2032, Analyzes DelveInsight | Key Companies - Moleculin Biotech, Monopar Therapeutics, and Others

22. Global Kidney Cancer Drugs Market to Surpass US$ 9.60 Billion by 2030 - Coherent Market Insights

23. Global Kidney Cancer Drugs Market to Surpass US$ 9.60 Billion by 2030 - Coherent Market Insights

24. Global Cancer Biomarkers Market to Surpass US$ 63,377.8 Million by 2030 - Coherent Market Insights

25. Global Cancer Biomarkers Market to Surpass US$ 63,377.8 Million by 2030 - Coherent Market Insights

26. Pituitary Cancer Market Size, Share, Growth, and Forecast to 2029 | DataMIntelligence

27. Drugs for Immunotherapy Global Market Report 2022

28. Drugs for Immunotherapy Global Market Report 2022

29. Bristol Myers Squibb optimistic about new launches

30. Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

31. Acral Lentiginous Melanoma Market Size: Industry Analysis, Key Companies, Emerging Drugs, Trends, Growth and Epidemiology Forecast by DelveInsight

32. Kaposi's Sarcoma Market: Industry Analysis, Leading Companies, Drugs, Pipeline Therapies and Competitive Analysis by DelveInsight

33. Global Immunotherapy Drugs Market Outlook 2021-2025 - Short & Long-term Impact of COVID-19, Delayed Approvals for Non-COVID-related Pharmaceutical Products, Changes in Consumption Trends

34. Immunotherapy Drugs Industry Assessment 2021 Featuring Comprehensive Profiles of Amgen, Bayer, Johnson & Johnson, Novartis, Pfizer, and Other Major Players - ResearchAndMarkets.com

35. Global Immunotherapy Drugs Market Outlook 2021-2025 - Short & Long-term Impact of COVID-19, Delayed Approvals for Non-COVID-related Pharmaceutical Products, Changes in Consumption Trends

36. Provectus Biopharmaceuticals Receives Notice of Allowance for Adult Solid Tumor Cancer Combination Therapy Patent for PV-10(R) Immunotherapy from United States Patent and Trademark Office

37. Immunotherapy Drugs: Global Markets Through 2019, 2020, and 2021-2025

38. BioAtla Announces Full Year 2020 Financial Results And Provides Business Update

39. Global Immunocytokines Market Report 2021-2030: Current and Future Potential of Immunocytokines Being Developed for the Treatment of Rheumatoid Arthritis and Various Types of Cancer

40. Immunotherapy Drugs Industry Assessment 2021 Featuring Comprehensive Profiles of Amgen, Bayer, Johnson & Johnson, Novartis, Pfizer, and Other Major Players

41. Global Natural Killer Cell Therapies Competitive Landscape, Technology, and Pipeline Analysis | DelveInsight

42. Global Natural Killer Cell Therapies Competitive Landscape, Technology, and Pipeline Analysis | DelveInsight

43. Global Colorectal Cancer Diagnostics and Therapeutics Market Report 2020: Immunotherapy Expected to Remain a Significant Revenue Source Due to Label Expansions Despite Approaching Patent Expiry

44. Global Colorectal Cancer Diagnostics and Therapeutics Market Report 2020: Immunotherapy Expected to Remain a Significant Revenue Source Due to Label Expansions Despite Approaching Patent Expiry

45. Provectus Biopharmaceuticals Announces Oral Presentation of Updated Data from Combination Therapy Trial of PV-10(R) and Keytruda(R) for Checkpoint-Refractory Advanced Cutaneous Melanoma at Melanoma Bridge 2020

46. Global Chronic Liver Disease Therapeutics Market to Surpass US$ 24.9 Billion by 2027, Says Coherent Market Insights

47. Global Chronic Liver Disease Therapeutics Market to Surpass US$ 24.9 Billion by 2027, Says Coherent Market Insights

48. Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030

49. Ipilimumab Market 2020-2025 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

50. Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030

Catalog

Books, media, physical & digital resources